| 1101/1644 | US=90 / Biol/Mol Xu W, Neckers L. EGFR signaling networks: differential dependence of EGFR and ErbB2 on the molecular chaperone Hsp90. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 63-71. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. CHAPERONES MOLECULARES; PROTEINA DE CHOQUE TERMICO 90; ANSAMICINAS BENZOQUINONA; GELDANAMICINA; HSP90 INIBIDOR; MUTACOES DE EGFR; SENSIBILIDADE AO FARMACO |
| 1102/1644 | US=90 / Biol/Mol Gavard J, Gutkind JS. EGFR signaling networks: a molecular crosstalk between e-cadlherin and EGFR signaling networks. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 139-54. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGFR; JUNCOES CELULARES; ADESAO CELULAR; CADERINA; CATENINA MIGRACAO; ACTINA |
| 1103/1644 | US=90 / Biol/Mol Eberhard DA. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: EGFR mutations, other molecular alterations related to sensitivity to EGFR-targeted therapies in non-small cell lung cancer. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 293-336. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DE QUINASE DE TIROSINA; DIAGNOSTICOS MOLECULARES; MUTACOES; HIBRIDACAO IN SITU FLUORESCENTE; IMUNOHISTOQUIMICA; CANCER DE PULMAO |
| 1104/1644 | US=90 / Biol/Mol Buck E, Eyzaguirre A, Iwata KK. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: utilizing combination of molecular targeted agents to sensitize tumor cells to EGFR inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 369-82. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EMT; TRANSICAO EPITELIAL MESENQUIMAL; ERLOTINIB; EGFR; IGF-1R; ER; HER3; MTOR; HDAC; SRC; COX-2 |
| 1105/1644 | US=1 / Química Kistler WS, Jamieson A. Tecnologia do DNA recombinante. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 487-510. ISBN 85-3522298-2. HIBRIDIZACAO MOLECULAR; AMPLIFICACAO DO DNA; CLONAGEM DO DNA; ANALISE DO DNA; SEQUENCIAMENTO DO DNA |
| 1106/1644 | US=1 / Quimioterapia Gaddis JS, Gullatte MM. Pharmacologic principles of chemotherapy. In: Gullatte MM, editor. Clinical guide to antineoplastic therapy: a chemotherapy handbook. 2nd ed. Pittsburgh: Oncology Nursing Society, 2007. p. 19-37. ISBN 978-1-890504-68-7. FARMACOLOGICOS DE QUIMIOTERAPIA; CICLO CELULAR DE RESPOSTA QUIMIOTERAPIA; AGENTES ANTINEOPLASICOS; AGENTES ALQUILANTES; TOXICIDADE DOS AGENTES ALQUILANTES; ANTIMETABOLITOS; TOXICIDADE ANTIMETABOLITO; ANTIBIOTICOS ANTITUMORAIS; FACTORES DE CRESCIMENTO HEMATOPOIETICOS; HORMONIOS; ALCALOIDES DE PLANTAS; TERAPIAS-ALVO MOLECULAR; ANTICORPOS MONOCLONAIS |
| 1107/1644 | US=107 / Câncer Shuker DEG. Socioeconomic and molecular basis of cancer. In: Missailidis S, editor. The cancer clock. New Jersey: John Wiley & Sons, 2007. p. 3-24. ISBN 978-0-470-06151-0. |
| 1108/1644 | US=111 / Câncer Alison MR, Burkert J, Wright NA, Leedham S. Stem cells and tumourigenesis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 22-35. ISBN 978-0-470-01852-1. CELULAS-TRONCO; TUMORIGENESE; CELULAS ESTAMINAIS ADULTAS; ORIGEM CELULAR DE CANCER; CELULAS CANCEROSAS ESTAMINAIS; REGULACAO MOLECULAR; CELULAS-TRONCO DERIVADAS DA MEDULA OSSEA |
| 1109/1644 | US=111 / Câncer Vineis P. Molecular epidemiology of cancer and the use of biomarkers. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 410-9. ISBN 978-0-470-01852-1. CANCER; CANCER; EPIDEMIOLOGIA MOLECULAR; BIOMARCADORES; MARCADORES DE DOSE INTERNA; MARCADORES DE RESPOSTA TARDIA; PROTEOMICOS; EPIGENETICA; MARCADORES DE SUSCETIBILIDADE |
| 1110/1644 | US=111 / Câncer Wilczynski SP. Introduction to the diagnosis of cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 477-91. ISBN 978-0-470-01852-1. CANCER; CANCER. DIAGNOSTICO; TRIAGEM; DETECCAO PRECOCE; DIAGNOSTICO DE ROTINA; DIAGNOSTICO MOLECULAR; DOENCA RESIDUAL MINIMA |
| 1111/1644 | US=111 / Câncer Hruban RH, Wilentz RE, Fukushima N, Goggins M. Pancreas. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 578-93. ISBN 978-0-470-01852-1. CANCER DE PANCREAS. EPIDEMIOLOGIA; CANCER DE PANCREAS. ETIOLOGIA; CANCER DE PANCREAS. TRIAGEM; CANCER DE PANCREAS. PREVENCAO; CANCER DE PANCREAS. GENETICA MOLECULAR; CANCER DE PANCREAS. FATORES PROGNOSTICOS |
| 1112/1644 | US=111 / Câncer Asa SL, Ezzat S. Endocrine organs. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 611-23. ISBN 978-0-470-01852-1. CANCER; ORGAOS ENDOCRINOS; CANCER DO SISTEMA ENDOCRINO; CANCER ENDOCRINO. EPIDEMIOLOGIA; CANCER ENDOCRINO. ETIOLOGIA; CANCER ENDOCRINO. TRIAGEM; CANCER ENDOCRINO. PREVENCAO; NODULOS FOLICULARES DA TIREOIDE; HIPERPLASIA PAPILAR; CARCINOMA PAPILAR; GENETICA MOLECULAR; CANCER ENDOCRINO. FATORES PROGNOSTICOS; CANCER ENDOCRINO. TERAPIA |
| 1113/1644 | US=111-A / Câncer Kashani-Sabet M. Melanoma. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 1360-70. ISBN 978-0-470-01852-1. CANCER. TERAPIA; MELANOMA. EPIDEMIOLOGIA; MELANOMA. ETIOLOGIA; MELANOMA. PATOGENESE; GENETICA MOLECULAR; MELANOMA. PROGNOSTICO; MELANOMA. ESTADIAMENTO; MELANOMA. TERAPIA |
| 1114/1644 | US=16 / Urologia Chung LWK, Huang WC, Sung SY, Wu D, Odero-Marah V, Zhau HE. Biology and imaging: cancer-host interactions. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 73-86. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; CANCER DE PROSTATA; METASTASE OSSEA; SINALIZACAO CELULAR; MODULACAO EPIGENETICA DA EXPRESSAO GENICA; TRANSICAO EPITELIAL/MESENQUIMAL; MATRIZES EXTRACELULARES; FATORES DE CRESCIMENTO; INFLAMACAO; ALVO MOLECULAR; TERAPIA; OSTEOMIMICRY; CELULAS-TRONCO; INTERACAO TUMOR ESTROMAL |
| 1115/1644 | US=16 / Urologia Lyer M, Gambhir SS. Biology and imaging: molecular imaging: noninvasive estrategies to visualize gene expression in living subjects. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 193-229. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; IMAGEM MOLECULAR; ESTRATEGIAS NAO-INVASIVAS; EXPRESSAO DO GENE; INDIVIDUOS VIVOS; IMAGEM DE BIOLUMINESCENCIA; GENE REPORTER; LUCIFERASE DE PIRILAMPO; HSV1-TK; IMAGEM MOLECULAR; TOMOGRAFIA POR EMISSAO DE POSITRONS; CANCER DE PROSTATA; AMPLIFICACAO DA TRANSCRICAO |
| 1116/1644 | US=16 / Urologia Gao X, Xing Y, Chung LWK, nie S. Biology and imaging: quantum doto nanotechnology for prostate cancer research. In: Chung LWK, Isaacs WB, Simons JW. Prostate cancer: biology, genetics, and the new therapeutics. 2ª ed. New Jersey: Humana Press, 2007. p. 231-44. (Contemporary Cancer Research) ISBN 978-1-58829-696-2. BIOLOGIA; IMAGEM; NANOTECNOLOGIA; PONTO QUANTICO; CANCER DE PROSTATA; PESQUISA; FLUORESCENCIA; IMAGEM MOLECULAR; TUMOR ALVO |
| 1117/1644 | US=21 / Neurologia Fuller GN. Classification of high-grade glioma: molecular classifications. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 37-42. (Current Clinical Oncology) ISBN 978-1-58829-511-8. GLIOMA DE ALTO GRAU; CLASSIFICACAO MOLECULAR; TRANSCRIPTOMICA; GENOMICA; PROTEOMICA; TISSUE MICROARRAY; MGMT; PTEN; 1P; 19Q |
| 1118/1644 | US=21 / Neurologia Roberts TPL, Kassner A. Diagnostic tools for high-grade glioma: imaging tumor biology: physiological and molecular insights. In: Barnett GH. High-grade gliomas: diagnosis and treatment. New Jersey: Humana Press, 2007. p. 141-59. (Current Clinical Oncology) ISBN 978-1-58829-511-8. GLIOMA DE ALTO GRAU. DIAGNOSTICO; BIOLOGIA DO TUMOR; RESSONANCIA MAGNETICA; ESPECTROSCOPIA DE RESSONANCIA MAGNETICA; DIFUSAO DE IMAGEM PONDERADA; TENSOR DE DIFUSAO DE IMAGENS |
| 1119/1644 | US=35 / Câncer Friedman AD. Molecular foundations of AML pathogenesis and physiology: aberrant transcription factors in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 27-42. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; FATORES DE TRANSCRICAO; RUNX1; C-MYB; MLL; HOXA9; WT1; EVI-1; C/EBPALFA; PU.1; RARALFA; GATA-1 |
| 1120/1644 | US=35 / Câncer Paker JE. Molecular foundations of AML pathogenesis and physiology: myelodysplasia-related AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 43-70. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; MIELODISPLASIA; SINDROMES MIELODISPLASICAS; LEUCEMOGENESE; APOPTOSE; PROLIFERACAO; CICLO CELULAR |